Gene · 7170
Papers3,595
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,595
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteomics separates adult-type diffuse high-grade gliomas in metabolic subgroups independent of 1p/19q codeletion and across IDH mutational status. | Cell Rep Med | 2023 | 36584682 | PubTator, text mining | PubMed |
| Acylations in cardiovascular biology and diseases, what's beyond acetylation. | EBioMedicine | 2023 | 36584593 | PubTator, text mining | PubMed |
| Current understanding of the cGAS-STING signaling pathway: Structure, regulatory mechanisms, and related diseases. | Zool Res | 2023 | 36579404 | PubTator, text mining | PubMed |
| A new intracellular targeting motif in the cytoplasmic tail of the spike protein may act as a target to inhibit SARS-CoV-2 assembly. | Antiviral Res | 2023 | 36572190 | PubTator, text mining | PubMed |
| Leveraging Molecular and Immune-Based Therapies in Leptomeningeal Metastases. | CNS Drugs | 2023 | 36474108 | PubTator, text mining | PubMed |
| Molecular characterization of genomic breakpoints of ALK rearrangements in non-small cell lung cancer. | Mol Oncol | 2023 | 36423218 | PubTator, text mining | PubMed |
| MET kinase inhibitor reverses resistance to entrectinib induced by hepatocyte growth factor in tumors with NTRK1 or ROS1 rearrangements. | Cancer Med | 2023 | 36416133 | PubTator, text mining | PubMed |
| NTRK-rearranged spindle cell neoplasms are ubiquitous tumours of myofibroblastic lineage with a distinct methylation class. | Histopathology | 2023 | 36413100 | PubTator, text mining | PubMed |
| Novel insights into congenital surfactant dysfunction disorders by in silico analysis of ABCA3 proteins. | World J Pediatr | 2023 | 36404394 | PubTator, text mining | PubMed |
| Structural Features Affecting the Interactions and Transportability of LAT1-Targeted Phenylalanine Drug Conjugates. | Mol Pharm | 2023 | 36394563 | PubTator, text mining | PubMed |
| ALK-rearranged renal cell carcinoma with TPM3::ALK gene fusion and review of the literature. | Virchows Arch | 2023 | 36370168 | PubTator, text mining | PubMed |
| Glial progenitor cells of the adult human white and grey matter are contextually distinct. | Glia | 2023 | 36334067 | PubTator, text mining | PubMed |
| NTRK rearrangements in a subset of NF1-related malignant peripheral nerve sheath tumors as novel actionable target. | Acta Neuropathol | 2023 | 36331594 | PubTator, text mining | PubMed |
| [MEN for multiple endocrin neoplasms: When evokate MEN? Update 2022]. | Rev Med Interne | 2023 | 36307322 | PubTator, text mining | PubMed |
| HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation. | Cell Mol Gastroenterol Hepatol | 2023 | 36244648 | PubTator, text mining | PubMed |
| A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets. | Nat Biotechnol | 2023 | 36217030 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Prevalence of NTRK Fusions in Canadian Solid Tumour Cancer Patients. | Mol Diagn Ther | 2023 | 36194351 | PubTator, text mining | PubMed |
| Molecular insights into the structural and dynamical changes of calcium channel TRPV6 induced by its interaction with phosphatidylinositol 4,5-bisphosphate. | J Biomol Struct Dyn | 2023 | 35950523 | PubTator, text mining | PubMed |
| Endometriosis and inflammatory immune responses: Indian experience. | Am J Reprod Immunol | 2023 | 35751585 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7170/papers?page=25